BIO - Bio-Rad Laboratories hits 52-week low; down 40% YTD
- Bio-Rad Laboratories ( NYSE: BIO ) on Monday hit a 52-week low of $436.90.
- Year to date, the stock is down ~40% . Over the last year, it is down ~43% .
- The life science research and clinical diagnostic products company was recently named a top pick in the healthcare sector by Citi .
For further details see:
Bio-Rad Laboratories hits 52-week low; down 40% YTD